Pep2Tango Therapeutics, a Versant Ventures-backed startup, is revolutionizing the obesity drug market with its innovative multi-target therapy that combines GLP-1, GIP, amylin, and calcitonin receptors. Under CEO Cristina Rondinone's leadership, the company aims to enhance fat loss while preserving muscle, a critical improvement over treatments like Novo Nordisk's Wegovy and Eli Lilly's Zepbound. Medhealth Review https://lnkd.in/ebPrB5KP #lifesciences
关于我们
We cover everything important across Life Sciences. Whether you're interested in the newest Fundraise, latest Trends, most innovative Companies, or the People that drive our industry, we make sure you stay up to date on it all.
- 网站
-
https://www.surveymonkey.com/r/Q29HSMJ
Life Sciences VCLink News的外部链接
- 所属行业
- 网络新闻
- 规模
- 1 人
动态
-
Australian biotech startup Celosia Therapeutics has secured $16.75M in one of the largest Series A rounds for an Australian biotech. With backing from Uniseed, UniSuper, and investor Iomar Barrett, the funds will fast-track the development of their novel ALS gene therapy, CTx1000. Matthew Ogg | Business Australia News https://lnkd.in/ewZXwz-B #lifesciences
Biotech Celosia Therapeutics raises $16.75m to treat ALS
businessnewsaustralia.com
-
Radiology IT innovator Sirona Medical has secured $42M in Series C funding, led by Avidity Partners with backing from 8VC and GreatPoint Ventures. The company, known for its cloud-based Sirona Unify platform, also announced the appointment of Hooman Hakami as CEO, with previous chief Cameron Andrews transitioning to president of the board. Marty Stempniak | Radiology Business https://lnkd.in/erkkUvYM #lifesciences
Radiology IT firm Sirona Medical raises $42M in Series C financing
radiologybusiness.com
-
Cradle Bio has successfully secured a $73M Series B round to accelerate the growth and adoption of its AI-powered protein-making software within the pharmaceutical industry. This funding highlights the continued focus on leveraging artificial intelligence in drug development. Andrew Dunn | Endpoints News https://lnkd.in/d5ZdfsB3 #lifesciences
Cradle Bio raises $73M Series B to sell pharma its protein-making AI software
endpts.com
-
Biolevate has raised €6 million in a Seed funding round led by EQT Ventures to revolutionize medical writing using AI-powered solutions. CEO Joel Belafa and his team aim to streamline and enhance documentation processes in the biotech sector, positioning their platform to support innovation and improve efficiency. Mike Butcher | TechCrunch https://lnkd.in/eXvDVniZ #lifesciences
Biolevate's raises €6M to helps medical writers keep up with the pace of new drugs | TechCrunch
https://techcrunch.com
-
Jupiter Bioventures has launched with an impressive $70 million fundraise to create transformational biotech companies driven by bold science and a 'science-first' model. Co-founders Nathaniel 'Ned' David and Norman 'Ned' Sharpless will use their decades of industry experience, alongside backing from investors like Mission BioCapital and Mayo Clinic. The venture aims to deliver groundbreaking therapeutics targeting cancer and other diseases. Mission BioCapital representative Zach Collins shared his excitement for driving these innovations forward. https://lnkd.in/eaUJsaE8 #lifesciences
Industry Veterans Announce Jupiter Bioventures, a Biotechnology Venture Foundry that Turns Novel Science into Transformational Companies
globenewswire.com
-
DANNCE.ai has successfully raised $2.6M in pre-seed funding to revolutionize neurological care using its AI-powered biomarkers platform. With investors like LDV Capital, Glasswing Ventures, and others, and leadership from Rob Baldoni, Dr. Tim Dunn, and Dr. Jesse Marshall, this innovative technology aims to enhance movement disorder diagnosis and treatment. GlobeNewswire https://lnkd.in/e-piaKzD #lifesciences
DANNCE.AI Raises $2.6 Million; Launches to Provide Clinicians and Drug Developers an AI Biomarkers Platform to Characterize Drug Effects and Optimize Neurological Care
globenewswire.com
-
US genetic engineering startup Colossal Biosciences has donated $2.3 million to the University of Melbourne to advance bird conservation genomics. The contribution will support efforts like genome sequencing, gene editing technologies, and conservation-oriented breeding programs. Startup Daily https://lnkd.in/eiZzawVr #lifesciences
Colossal, the US biotech that wants to use DNA to bring the dodo and Tassie tiger back from extinction, donated $2.3 million to the University of Melbourne
https://www.startupdaily.net
-
Adcendo, a Denmark-based ADC biotech, has raised $135 million in its Series B round, led by TCGX and joined by other notable investors like TPG Life Sciences Innovations, OrbiMed, and Venrock. This funding will support the company's advancement into clinical trials. Kyle LaHucik | Endpoints News https://lnkd.in/duunZ4JK #lifesciences
ADC biotech Adcendo nabs $135M Series B as it enters the clinic
endpts.com
-
Freya Biosciences has secured $10.4M in funding from the Bill & Melinda Gates Foundation, with additional support from Export and Investment Fund of Denmark, to advance microbial immunotherapies addressing bacterial vaginosis (BV) and its impact on preterm birth. CEO Colleen Acosta and Chairman Peter Bisgaard emphasize Freya’s commitment to transforming women's health globally, especially in resource-constrained settings. ArcticStartup https://lnkd.in/eVedbDUb #lifesciences
Danish biotech startup raises $10.4M to advance women’s health therapies
https://bebeez.eu